Strong Top-Line and EPS Growth
Q1 revenue of $153.0M, up 16% year-over-year and at the high end of guidance. Adjusted EPS of $0.27, up 50% YoY and above the high end of guided range.
Segment Revenue Momentum — Precision Devices
Precision Devices Q1 revenue $85M, up 17% YoY with broad-based growth across medtech, defense, industrial and electrification. Book-to-bill of 1.19 (sixth consecutive quarter >1) signaling strong order momentum and a robust backlog.
Segment Revenue — MedTech & Specialty Audio
MedTech & Specialty Audio (MSA) Q1 revenue $68M, up 14% YoY driven by customers' new product introductions and increased hearing health shipments.
Gross Margin Expansion
Company Q1 gross margin drivers: MSA gross margin 53.5%, up 480 basis points YoY (but expected to normalize near 51% for 2026); Precision Devices gross margin 39.2%, up 350 basis points YoY driven by improved pricing and higher capacity utilization.
Positive Guidance and Back Half Upside
Q2 revenue guidance $152M–$162M (midpoint +8% YoY). Q2 adjusted EBIT margin guidance 20%–22% and EPS guidance $0.28–$0.32 (midpoint +25% YoY). Management expects 2026 revenue growth above prior organic targets and adjusted EBITDA growth above the cumulative 10%–14% annual target.
Energy Order and Specialty Film Ramp
Execution on a $25M+ energy order is on track to be fully ramped by end of Q2, expected to contribute materially in the back half of 2026 and drive ~200–250 basis points of incremental PD margin improvement vs. current levels.
Solid Liquidity and Conservative Leverage
Exited Q1 with $41M cash, $131M borrowings under the revolver, net leverage of 0.6x (TTM adjusted EBITDA), and total liquidity >$310M (cash + undrawn revolver capacity).
Capital Allocation Actions
Repurchased 276k shares in Q1 for $7.5M; Q2 capex guidance $8M and full-year capex expected ~4%–5% of revenues to support capacity expansion tied to large orders.